Prospective Review of Procalcitonin After Cardiac Surgery
Prospective Review of Procalcitonin After Cardiac Surgery
This study is designed to demonstrate the value of Procalcitonin (PCT) in assisting the rapid
 diagnosis of post- operative infection that includes elevation of Procalcitonin above and
 beyond the changes seen with the acute and inflammatory response induced by cardio-pulmonary
 bypass.

 Procalcitonin is an innovative and highly specific biomarker for clinically relevant severe
 bacterial infections and sepsis. PCT supports early diagnosis and clinical decision
 making.This is a prospective single center study designed to assess the normal change in PCT
 levels following major surgery and the utilization of PCT regarding the diagnosis of
 infection and the response to treatment, following major cardiac surgery
Inclusion Criteria:

 Elective CABG + / - Aortic / Mitral valve patients Off pump and on pump cases

 Exclusion Criteria:

 Patients with recent infection in last week and / or Antibiotics in last 1 week or pre op
 fever > 99.5f / 38C in 24hrs prior to surgery Patients on oral or IV corticosteroids within 1
 week of being on them. Known immune dysfunction Active congestive heart failure / Recovering
 from cardiogenic shock\ Intra aortic balloon pump pre - op No CABG patients with CRYO MAZE,
 or Ablation
Inclusion Criteria:

 Elective CABG + / - Aortic / Mitral valve patients Off pump and on pump cases

 Exclusion Criteria:

 Exclusion Criteria:

 Check any box that applies:

 Patients with recent infection in last week and / or Antibiotics in last 1 week or pre op
 fever > 99.5f / 38C in 24hrs prior to surgery Patients on oral or IV corticosteroids within
 1 week of being on them. Known immune dysfunction Active congestive heart failure /
 Recovering from cardiogenic shock\ Intra aortic balloon pump pre - op No CABG patients with
 CRYO MAZE, or Ablation